Search

Your search keyword '"Katz, Stephanie"' showing total 47 results
Start Over Author "Katz, Stephanie"
47 results on '"Katz, Stephanie"'

1. Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

Author

Adams, Tanya, Amjad, Sophia, Appelhans, Christina, Applegate, Tanya, Becker, Brigitta, Bhagani, Sanjay, Bouchard, Rachel, Braun, Dominique, Bruelisauer, Christine, Bruneau, Julie, Calcagnile, Selma, Carroll, Anne, Cerocchi, Orlando, Chronister, Karen, Cordes, Christiane, Dore, Greg, Evans, Fiona, Fedele, Serge, Feld, Jordan, Ferguson, Catherine, Fraser, Chris, Ganase, Bruce, Gane, Ed, George, Valerie, Gerlach, Christoph, Gilleece, Yvonne, Gilliver, Rosie, Grebely, Jason, Grube, Christina, Gustafson, Jenna, Haas, Annette, Hagenauer, Michelle, Harris, Marianne, Helder, Jeltje, Hellard, Margaret, Hirter, Daniela, Hull, Mark, Ingiliz, Patrick, Katz, Stephanie, Kim, Arthur, Kotsoros, Barbara, Lacalamita, Melanie, Lindergard, Gabriella, Lutz, Thomas, Macabodbod, Lester, Manz, Manuela, Marks, Pip, Martinello, Marianne, Matthews, Gail, Messina, Paola, Mohrmann, Karina, Monnich, Christine, Moon, Juhi, Moriggia, Alberto, Morris, Genevieve, Morrish, Thomas, Nelson, Mark, Oliver, Victoria, Patterson, Joanne, Peters, Martine, Petoumenos, Kathy, Porretta, Hadassa, Rauch, Andri, Raymode, Parizade, Read, Phillip, Reece, Stacey, Rockstroh, Jürgen, Saidi, Angelika, Sasadeusz, Joe, Scherler, Pia, Schröder, Reinhold, Selfridge, Marion, Sevehon, Alison, Shaw, David, Sulkowski, Mark, Tamaddoni, Mahshid, Thunder, Orla, Thurnheer, Maria Christine, Tu, Elise, Ustianowski, Andrew, van der Valk, Marc, Witele, Eric, Koopsen, Jelle, Rockstroh, Juergen, Applegate, Tanya L, Sacks-Davis, Rachel, Boesecke, Christoph, Rebers, Sjoerd, Dore, Gregory J, and Schinkel, Janke

Published
2023
Full Text
View/download PDF

3. Structure of the MRAS–SHOC2–PP1C phosphatase complex

Author

Hauseman, Zachary J., Fodor, Michelle, Dhembi, Anxhela, Viscomi, Jessica, Egli, David, Bleu, Melusine, Katz, Stephanie, Park, Eunyoung, Jang, Dong Man, Porter, Kathryn A., Meili, Fabian, Guo, Hongqiu, Kerr, Grainne, Mollé, Sandra, Velez-Vega, Camilo, Beyer, Kim S., Galli, Giorgio G., Maira, Saveur-Michel, Stams, Travis, Clark, Kirk, Eck, Michael J., Tordella, Luca, Thoma, Claudio R., and King, Daniel A.

Published
2022
Full Text
View/download PDF

4. Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine

Author

Verma, Malvika, Chu, Jacqueline N., Salam, John A. F., Faiz, Mohammed T., Eweje, Feyisope, Gwynne, Declan, Lopes, Aaron, Hess, Kaitlyn, Soares, Vance, Steiger, Christoph, McManus, Rebecca, Koeppen, Ryan, Hua, Tiffany, Hayward, Alison, Collins, Joy, Tamang, Siddartha M., Ishida, Keiko, Miller, Jonathan B., Katz, Stephanie, Slocum, Alexander H., Sulkowski, Mark S., Thomas, David L., Langer, Robert, and Traverso, Giovanni

Published
2020

10. Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

Author

Koopsen, Jelle, primary, Matthews, Gail, additional, Rockstroh, Juergen, additional, Applegate, Tanya L, additional, Bhagani, Sanjay, additional, Rauch, Andri, additional, Grebely, Jason, additional, Sacks-Davis, Rachel, additional, Ingiliz, Patrick, additional, Boesecke, Christoph, additional, Rebers, Sjoerd, additional, Feld, Jordan, additional, Bruneau, Julie, additional, Martinello, Marianne, additional, Hellard, Margaret, additional, Dore, Gregory J, additional, Schinkel, Janke, additional, van der Valk, Marc, additional, Adams, Tanya, additional, Amjad, Sophia, additional, Appelhans, Christina, additional, Applegate, Tanya, additional, Becker, Brigitta, additional, Bouchard, Rachel, additional, Braun, Dominique, additional, Bruelisauer, Christine, additional, Calcagnile, Selma, additional, Carroll, Anne, additional, Cerocchi, Orlando, additional, Chronister, Karen, additional, Cordes, Christiane, additional, Dore, Greg, additional, Evans, Fiona, additional, Fedele, Serge, additional, Ferguson, Catherine, additional, Fraser, Chris, additional, Ganase, Bruce, additional, Gane, Ed, additional, George, Valerie, additional, Gerlach, Christoph, additional, Gilleece, Yvonne, additional, Gilliver, Rosie, additional, Grube, Christina, additional, Gustafson, Jenna, additional, Haas, Annette, additional, Hagenauer, Michelle, additional, Harris, Marianne, additional, Helder, Jeltje, additional, Hirter, Daniela, additional, Hull, Mark, additional, Katz, Stephanie, additional, Kim, Arthur, additional, Kotsoros, Barbara, additional, Lacalamita, Melanie, additional, Lindergard, Gabriella, additional, Lutz, Thomas, additional, Macabodbod, Lester, additional, Manz, Manuela, additional, Marks, Pip, additional, Messina, Paola, additional, Mohrmann, Karina, additional, Monnich, Christine, additional, Moon, Juhi, additional, Moriggia, Alberto, additional, Morris, Genevieve, additional, Morrish, Thomas, additional, Nelson, Mark, additional, Oliver, Victoria, additional, Patterson, Joanne, additional, Peters, Martine, additional, Petoumenos, Kathy, additional, Porretta, Hadassa, additional, Raymode, Parizade, additional, Read, Phillip, additional, Reece, Stacey, additional, Rockstroh, Jürgen, additional, Saidi, Angelika, additional, Sasadeusz, Joe, additional, Scherler, Pia, additional, Schröder, Reinhold, additional, Selfridge, Marion, additional, Sevehon, Alison, additional, Shaw, David, additional, Sulkowski, Mark, additional, Tamaddoni, Mahshid, additional, Thunder, Orla, additional, Thurnheer, Maria Christine, additional, Tu, Elise, additional, Ustianowski, Andrew, additional, and Witele, Eric, additional

Published
2023
Full Text
View/download PDF

11. Pre-TAVR Systemic Pulsatility Index Predicts Mortality In Patients With Left Ventricular Dysfunction And Severe Aortic Stenosis

Author

Selinski, Christian, primary, Strickling, Jarred, additional, Katz, Stephanie, additional, Rojas-Pena, Edward, additional, Ashur, Nicholas, additional, Bilchick, Kenneth, additional, Lim, Scott, additional, Taylor, Angela, additional, Ragosta, Michael, additional, Mehta, Nishaki, additional, Breathett, Khadijah, additional, and Mazimba, Sula, additional

Published
2023
Full Text
View/download PDF

14. Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments

Author

Mark S. Sulkowski, Jordan J. Feld, Katz Stephanie, Ethel D. Weld, Sunil S. Solomon, Gail V. Matthews, Charles Flexner, Jacqueline Astemborski, Shruti H. Mehta, Richard E. Rothman, Giovanni Traverso, Susan Swindells, Yu-Hsiang Hsieh, Andrew Owen, David L. Thomas, Gregory D. Kirk, and Malvika Verma

Subjects
Microbiology (medical), Adult, medicine.medical_specialty, business.industry, Hepatitis C virus, Hepatitis C, Hepacivirus, medicine.disease, medicine.disease_cause, Antiviral Agents, Infectious Diseases, Long acting, Cross-Sectional Studies, Pill, Internal medicine, Child, Preschool, Hcv treatment, Major Article, Medicine, Humans, Female, Implant, business
Abstract

Background Whereas safe, curative treatments for hepatitis C virus (HCV) have been available since 2015, there are still 58 million infected persons worldwide, and global elimination may require new paradigms. We sought to understand the acceptability of approaches to long-acting HCV treatment. Methods A cross-sectional, 43-question survey was administered to 1457 individuals with or at risk of HCV at 28 sites in 9 countries to assess comparative interest in a variety of long-acting strategies in comparison with oral pills. Results Among HCV-positive participants, 37.7% most preferred an injection, 5.6% an implant, and 6% a gastric residence device, as compared with 50.8% who stated they would most prefer taking 1–3 pills per day. When compared directly to taking pills, differences were observed in the relative preference for an injection based on age (P Conclusions These data point to high acceptability of long-acting treatments, which for a substantial minority might even be preferred to pills for the treatment of HCV infection. Long-acting treatments for HCV infection might contribute to global efforts to eliminate hepatitis C.

Published
2021

15. Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments

Author

Weld, Ethel D, primary, Astemborski, Jacqueline, additional, Kirk, Gregory D, additional, Sulkowski, Mark S, additional, Katz, Stephanie, additional, Rothman, Richard, additional, Solomon, Sunil S, additional, Matthews, Gail V, additional, Hsieh, Yu Hsiang, additional, Verma, Malvika, additional, Traverso, Giovanni, additional, Swindells, Susan, additional, Owen, Andrew, additional, Feld, Jordan, additional, Flexner, Charles, additional, Mehta, Shruti H, additional, and Thomas, David L, additional

Published
2021
Full Text
View/download PDF

16. Nonadherence to Ledipasvir/Sofosbuvir Did Not Predict Sustained Virologic Response in a Randomized Controlled Trial of Human Immunodeficiency Virus/Hepatitis C Virus Coinfected Persons Who Use Drugs

Author

Ward, Kathleen M, primary, Falade-Nwulia, Oluwaseun, additional, Moon, Juhi, additional, Sutcliffe, Catherine G, additional, Brinkley, Sherilyn, additional, Haselhuhn, Taryn, additional, Katz, Stephanie, additional, Herne, Kayla, additional, Arteaga, Lilian, additional, Mehta, Shruti H, additional, Latkin, Carl, additional, Brooner, Robert K, additional, and Sulkowski, Mark S, additional

Published
2021
Full Text
View/download PDF

17. Publishing a Literary Magazine in the Library.

Author

Katz, Stephanie

Subjects
*LITERARY magazines, *INTERNET publishing, *PUBLIC libraries, *SUBSCRIPTIONS to serial publications
Abstract

805 Lit + Artis a literary and art journal published online atwww.805lit.organd in print by the Manatee County Public Library. Founded in 2015,805has six online issues, an annual dedicated teen issue, and an annual print anthology.805publishes original art, poetry, fiction, and nonfiction from emerging artists and writers internationally. Subscriptions and submissions are free, and805has spurred successful programming, outreach, internships, and community partnerships for the library. The editors of805grapple with running a creative journal based on library values versus potential censorship from the public and parent organizations. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

18. Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.

Author

Weld, Ethel D, Astemborski, Jacqueline, Kirk, Gregory D, Sulkowski, Mark S, Katz, Stephanie, Rothman, Richard, Solomon, Sunil S, Matthews, Gail V, Hsieh, Yu Hsiang, Verma, Malvika, Traverso, Giovanni, Swindells, Susan, Owen, Andrew, Feld, Jordan, Flexner, Charles, Mehta, Shruti H, and Thomas, David L

Subjects
HEPATITIS C treatment, HEPATITIS C risk factors, DRUG delivery systems, CROSS-sectional method, PATIENTS' attitudes, DESCRIPTIVE statistics
Abstract

Background Whereas safe, curative treatments for hepatitis C virus (HCV) have been available since 2015, there are still 58 million infected persons worldwide, and global elimination may require new paradigms. We sought to understand the acceptability of approaches to long-acting HCV treatment. Methods A cross-sectional, 43-question survey was administered to 1457 individuals with or at risk of HCV at 28 sites in 9 countries to assess comparative interest in a variety of long-acting strategies in comparison with oral pills. Results Among HCV-positive participants, 37.7% most preferred an injection, 5.6% an implant, and 6% a gastric residence device, as compared with 50.8% who stated they would most prefer taking 1–3 pills per day. When compared directly to taking pills, differences were observed in the relative preference for an injection based on age (P <.001), location (P <.001), and prior receipt of HCV treatment (P =.005) but not sex. When an implant was compared with pills, greater preference was represented by women (P =.01) and adults of younger ages (P =.01 per 5 years). Among participants without HCV, 49.5% believed that injections are stronger than pills and 34.7% preferred taking injections to pills. Among those at-risk participants who had received injectable medications in the past, 123 of 137 (89.8%) expressed willingness to receive one in the future. Conclusions These data point to high acceptability of long-acting treatments, which for a substantial minority might even be preferred to pills for the treatment of HCV infection. Long-acting treatments for HCV infection might contribute to global efforts to eliminate hepatitis C. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

21. Sa1527 DEVELOPMENT OF A LONG-ACTING DIRECT-ACTING ANTIVIRAL SYSTEM FOR HEPATITIS C VIRUS TREATMENT IN A SWINE MODEL

Author

Verma, Malvika, primary, Chu, Jacqueline N., additional, Salama, John A., additional, Faiz, Mohammed T., additional, Gwynne, Feyisope Ew Declan, additional, Lopes, Aaron, additional, Hess, Kaitlyn, additional, Soares, Vance, additional, Steiger, Christoph, additional, McManus, Rebecca, additional, Koeppen, Ryan, additional, Hua, Tiffany, additional, Hayward, Alison, additional, Collins, Joy E., additional, Tamang, Siddartha, additional, Ishida, Keiko, additional, Miller, Jonathan B., additional, Katz, Stephanie, additional, Slocum, Alexander H., additional, Sulkowski, Mark, additional, Thomas, David L., additional, Langer, Robert, additional, and Traverso, Giovanni, additional

Published
2020
Full Text
View/download PDF

22. Unreported alcohol use was common but did not impact hepatitis C cure in HIV‐infected persons who use drugs

Author

Irvin, Risha, primary, Chander, Geetanjali, additional, Ward, Kathleen M., additional, Manogue, Sean, additional, Falade‐Nwulia, Oluwaseun, additional, Moon, Juhi, additional, Sutcliffe, Catherine G., additional, Brinkley, Sherilyn, additional, Haselhuhn, Taryn, additional, Katz, Stephanie, additional, Herne, Kayla, additional, Arteaga, Lilian, additional, Thomas, David L., additional, Mehta, Shruti H., additional, and Sulkowski, Mark S., additional

Published
2020
Full Text
View/download PDF

24. Synthesis, characterization, and solution properties of skeletally stabilized triphophazanes

Author

Helm, Monte L., Katz, Stephanie A., Imiolczyk, Tomasz W., Hands, Robert M., and Norman, Arlan D.

Subjects
Coordination compounds -- Research, Phosphazo compounds -- Research, Nuclear magnetic resonance spectroscopy -- Usage, Chemistry
Abstract

Three new dicholorotriphosphazanes were prepared by reacting PhPCl2 with 1,2-(NH2)2C6H4, MePCls with 1,2-(Me3SiNH)2C6H4 and PhPCl2 with phosphadiazole C2H4(me3SiN)2PPh. The dicholorotriphosphazanes generated are C6H4N2(PhPCl)2PPh, C6H4N2(MePCl)2PMe and C2H4N2(PhPCl)2PPh. Their nuclear magnetic resonance (NMR) spectra in nonpolar solvents show that they are mixtures of three diastereomers. It was also observed that the NMR spectra of the first two dicholorotriphosphazanes are influenced by temperature, solvent donor and dielectric strength.

Published
1999

25. Nonadherence to Ledipasvir/Sofosbuvir Did Not Predict Sustained Virologic Response in a Randomized Controlled Trial of Human Immunodeficiency Virus/Hepatitis C Virus Coinfected Persons Who Use Drugs.

Author

Ward, Kathleen M, Falade-Nwulia, Oluwaseun, Moon, Juhi, Sutcliffe, Catherine G, Brinkley, Sherilyn, Haselhuhn, Taryn, Katz, Stephanie, Herne, Kayla, Arteaga, Lilian, Mehta, Shruti H, Latkin, Carl, Brooner, Robert K, and Sulkowski, Mark S

Subjects
HEPATITIS C virus, HIV, RANDOMIZED controlled trials, RANDOMIZED response, SOFOSBUVIR, HIV infection complications, HIV infections, RESEARCH, SUBSTANCE abuse, CHRONIC hepatitis C, HETEROCYCLIC compounds, RESEARCH methodology, HEPATITIS C, HEPATITIS viruses, ANTIVIRAL agents, EVALUATION research, TREATMENT effectiveness, HYDROCARBONS, COMPARATIVE studies, MIXED infections, DRUGS, RESEARCH funding, STATISTICAL sampling, PHARMACODYNAMICS, DISEASE complications
Abstract

Background: Eliminating hepatitis C virus (HCV) will require effective treatment delivery to persons with substance use disorders (SUDs). We evaluated the relationship between ledipasvir/sofosbuvir treatment persistence (receiving 84 tablets), adherence, and sustained virologic response (SVR) in persons with human immunodeficiency virus (HIV)/HCV coinfection.Methods: Of the 144 participants with HIV/HCV and SUDs, 110 initiated a 12-week treatment course under 1 of 3 conditions (usual care, peer mentors, and cash incentives). We used self-report, pharmacy pill counts, and expected date of refill to examine adherence. Persistent participants were categorized as high adherence (taking ≥90% of doses) or low adherence (taking <90% of doses).Results: Most participants persisted on treatment after initiation (n = 105), with 95% (n = 100) achieving SVR. One third (34%) of participants had moderate/heavy alcohol use by the biomarker phosphatidylethanol ([Peth] ≥50 ng/mL), and 44% had urine toxicology positive for cocaine or heroin at enrollment. The proportion of persons with high adherence was 72% (n = 76), and the proportion of persons with low adherence was 28%. Although low adherence was associated with moderate/heavy alcohol use by PEth (relative risk = 2.77; 95% confidence interval, 1.50-5.12), SVR did not vary according to adherence (P = .702), and most participants (97%) with low adherence achieved SVR.Conclusions: Treatment persistence led to high SVR rates among persons with HIV/HCV, despite imperfect adherence and SUDs. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

26. Books with Bearded Dragons: The lizards bring laid-back fun and learning to a school library

Author

Katz, Stephanie

Subjects
Children's libraries -- Social aspects, Human-animal relationships -- Social aspects, School libraries, Pets -- Appreciation, Education, Library and information science, Publishing industry
Abstract

While many librarians are devoted to their resident felines, others prefer cozying up to bearded dragon lizards, or 'beardies.' Library media specialists who have beardies on-site agree that these lizards [...]

Published
2021

28. Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine

Author

Massachusetts Institute of Technology. Department of Biological Engineering, Massachusetts Institute of Technology. Tata Center for Technology and Design, Massachusetts Institute of Technology. Department of Chemical Engineering, Massachusetts Institute of Technology. Division of Comparative Medicine, Sloan School of Management, Massachusetts Institute of Technology. Department of Mechanical Engineering, Koch Institute for Integrative Cancer Research at MIT, Verma, Malvika, Chu, Jacqueline N, Salama, John Ashraf Fou, Faiz, Mohammed T., Eweje, Feyisope, Gwynne, Declan A, Lopes, Aaron C, Hess, Kaitlyn, Soares, Vance, Steiger, Christoph Winfried Johannes, McManus, Rebecca S, Koeppen, Ryan P., Hua, Tiffany P, Hayward, Alison M, Collins, Joy E, Tamang, Siddartha M, Ishida, Keiko, Miller, Jonathan B., Katz, Stephanie, Slocum, Alexander H, Sulkowski, Mark S., Thomas, David L., Langer, Robert S, Traverso, Carlo Giovanni, Massachusetts Institute of Technology. Department of Biological Engineering, Massachusetts Institute of Technology. Tata Center for Technology and Design, Massachusetts Institute of Technology. Department of Chemical Engineering, Massachusetts Institute of Technology. Division of Comparative Medicine, Sloan School of Management, Massachusetts Institute of Technology. Department of Mechanical Engineering, Koch Institute for Integrative Cancer Research at MIT, Verma, Malvika, Chu, Jacqueline N, Salama, John Ashraf Fou, Faiz, Mohammed T., Eweje, Feyisope, Gwynne, Declan A, Lopes, Aaron C, Hess, Kaitlyn, Soares, Vance, Steiger, Christoph Winfried Johannes, McManus, Rebecca S, Koeppen, Ryan P., Hua, Tiffany P, Hayward, Alison M, Collins, Joy E, Tamang, Siddartha M, Ishida, Keiko, Miller, Jonathan B., Katz, Stephanie, Slocum, Alexander H, Sulkowski, Mark S., Thomas, David L., Langer, Robert S, and Traverso, Carlo Giovanni

Abstract

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis worldwide and kills more Americans than 59 other infections, including HIV and tuberculosis, combined. While direct-acting antiviral (DAA) treatments are effective, limited uptake of therapy, particularly in high-risk groups, remains a substantial barrier to eliminating HCV. We developed a long-acting DAA system (LA-DAAS) capable of prolonged dosing and explored its cost-effectiveness. We designed a retrievable coil-shaped LA-DAAS compatible with nasogastric tube administration and the capacity to encapsulate and release gram levels of drugs while resident in the stomach. We formulated DAAs in drug-polymer pills and studied the release kinetics for 1 mo in vitro and in vivo in a swine model. The LA-DAAS was equipped with ethanol and temperature sensors linked via Bluetooth to a phone application to provide patient engagement. We then performed a cost-effectiveness analysis comparing LA-DAAS to DAA alone in various patient groups, including people who inject drugs. Tunable release kinetics of DAAs was enabled for 1 mo with drug-polymer pills in vitro, and the LA-DAAS safely and successfully provided at least month-long release of sofosbuvir in vivo. Temperature and alcohol sensors could interface with external sources for at least 1 mo. The LA-DAAS was cost-effective compared to DAA therapy alone in all groups considered (base case incremental cost-effectiveness ratio $39,800). We believe that the LA-DAA system can provide a cost-effective and patient-centric method for HCV treatment, including in high-risk populations who are currently undertreated., NIH (Grants EB000244 and 5T32DK007191-45)

Published
2020

29. Cis/Trans isomerization and conformational properties of 2,4-bis(primary amino)-1,3,2,4-diazadiphosphetidines

Author

Hill, Tara G., Haltiwanger, R. Curtis, Thompson, Martin L., Katz, Stephanie A., and Norman, Arlan D.

Subjects
Ethers -- Research, Chemistry
Abstract

Alkyl substituted 1,3,2, 4-diazadiphosphetidines are prepared from RNH2/PCl3 in a medium of petroleum ethers. Cis isomer is favored, as the bulk of the alkyl substituent is increased. The temperature dependent 3' PNMR spectra reveals that transdiazadiphosphetidines are temperature-independent up to 90 degrees Celsius. Rotational barriers around the exo P-N bands are more for cis isomers than for trans isomers.

Published
1994

30. Diastereoselectivity in the formation of skeletally stabilized phosphazanes

Author

Katz, Stephanie, Allured, Viloya S., and Norman, Arlan D.

Subjects
Phosphazo compounds -- Research, Cyclic compounds -- Research, Chemistry
Abstract

Reactions of phosphadiazoles produce skeletally stabilized di and triphosphazanes. All the reactions are stereoselective and are compared with previously reported cyclic analogs. X-ray analysis is used to prove absolute stereochemistry and the compounds are characterized by spectral data.

Published
1994

31. A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study

Author

Ward, Kathleen M, primary, Falade-Nwulia, Oluwaseun, additional, Moon, Juhi, additional, Sutcliffe, Catherine G, additional, Brinkley, Sherilyn, additional, Haselhuhn, Taryn, additional, Katz, Stephanie, additional, Herne, Kayla, additional, Arteaga, Lilian, additional, Mehta, Shruti H, additional, Latkin, Carl, additional, Brooner, Robert K, additional, and Sulkowski, Mark S, additional

Published
2019
Full Text
View/download PDF

32. Publishing Teen Writers: Amplify Teen Voices Through Library Publications: Library publishing can be an easy way for teens to activate their voices.

Author

Katz, Stephanie

Subjects
*YOUNG adult literature, *TEENAGERS, *MEMOIRS, *YOUNG adults, *VOLUNTEER service
Abstract

The article discusses how library publications can help teenagers take the first step on their personal and professional writing paths and activate their voices. Topics covered include types of teen publications, types of teen writing and how to promote a future of diverse writing professionals. It also describes how to publish teens during times of crisis such as the COVID-19 pandemic and offers tips to attract teen writers.

Published
2021

34. Library as Publisher: 805 Lit + Art Journal.

Author

Katz, Stephanie, DeSear, Courtney, and Johnson, Jyna

Subjects
*SCHOLARLY periodicals, *LIBRARY publishing, *PUBLIC librarians, *INTERNET publishing, *EDITORS, *FEE-based library services
Abstract

The article offers information on 805 Lit + Art, an online literary and arts journal, founded and published by Manatee County Public Library System (MCPLS) in January 2015. Topics discussed include the journal run by team including editors, local fiction writer and former employees of MCPLS, publishing online due to access and money as publishing online is free and not charging fee from subscribers for making it accessible to who cannot afford the fees.

Published
2016

42. Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study.

Author

Ward, Kathleen M, Falade-Nwulia, Oluwaseun, Moon, Juhi, Sutcliffe, Catherine G, Brinkley, Sherilyn, Haselhuhn, Taryn, Katz, Stephanie, Herne, Kayla, Arteaga, Lilian, Mehta, Shruti H, Latkin, Carl, Brooner, Robert K, and Sulkowski, Mark S

Subjects
THERAPEUTICS, RANDOMIZED controlled trials, DRUG abuse, HIV, SUBSTANCE-induced disorders
Published
2019
Full Text
View/download PDF

47. Pacemaker Artifact in Lung Scan

Author

Blum, Manfred, Katz, Stephanie, and Scapicchio, Michael

Abstract

To the Editor:—An artifact which simulated a pulmonary embolus was produced in a lung scan by an indwelling cardiac pacemaker. Postmortem study confirmed the absence of such emboli. It was found that the battery pack of the pacemaker absorbs approximately 50% of the131I gamma emission from the injected radioactive pharmaceutical.Report of a Case:—A 74-year-old white man with diabetes who had an indwelling cardiac pacemaker implanted because of heart block was admitted to the surgical service on June 23, 1968. Gangrene involving the toes of the right foot was present. Five days later an amputation was performed below the knee of the right leg. The postoperative course was complicated by persistant irregularity of the cardiac rhythm without clinical, electrocardiographic, or chemical evidence of myocardial damage, and on Aug 12, the patient was taken to the operating room for exploration of the pacemaker apparatus. The device was

Published
1969
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results